Michael Rossi
Chief Executive Officer at Y-MABS THERAPEUTICS, INC.
Net worth: 1 M $ as of Today
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Gad | M | 54 | 9 years | |
| Bo Kruse | M | 52 | 9 years | |
| James Healy | M | 59 | 7 years | |
| David Gill | M | 69 | 7 years | |
| Johan Ernst Wedell-Wedellsborg | M | 54 | 9 years | |
| Ashutosh Tyagi | M | 47 | 7 years | |
| Gérard Ber | M | 66 | 6 years | |
| Joris Wilms | M | 50 | 8 years | |
| Laura Hamill | F | 60 | 4 years | |
| Torben Lund-Hansen | M | 73 | 8 years | |
| Vignesh Rajah | M | 59 | 4 years | |
| Sue Smith | F | 54 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jyothsna Natauri | F | 46 | 2 years | |
| Martyn Coombs | M | - |
Jubilant Draximage, Inc.
 Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | 4 years |
| Steen Lisby | M | 60 | 7 years | |
| David Vanevenhoven | M | 40 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 13 | 81.25% |
| Canada | 1 | 6.25% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Rossi
- Personal Network
